You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Medtronic has a long record of being proactive in establishing policies and practices that support strong corporate governance and transparency in financial reporting. These policies and practices are continually reviewed and enhanced as appropriate. We are fortunate to have a capable, highly engaged and fiercely independent Board of Directors who take corporate governance very seriously. As a result, we were able to anticipate and incorporate many of the leading edge practices well before they were mandated by recent corporate reform measures.
Routinely at each meeting of the Board of Directors, including committee meetings, the Board meets privately in executive session, without any other members of management present.
The Board has direct access to independent experts — lawyers, accountants and compensation experts — to turn to for counsel regarding specific Medtronic policies and activities.
The Audit Committee of the Board meets privately with the head of our internal audit group, and then privately with our independent auditors at the end of each Audit Committee meeting. Our Audit Committee pre-approves all audit and permitted non-audit services, and reviews quarterly and year-end financial statements and associated press releases with our financial management and outside, independent auditors in advance of their release.
The head of our Corporate Governance Committee serves as our lead director, and has private access to any member of management. He also acts as a clearinghouse for Board meeting agenda topics or any requests from individual Board members.
While Medtronic has excellent corporate governance systems and financial controls already in place, there is no substitute for strong Board members and effective corporate management who understand their duties to safeguard the Company and the interests of shareholders. Medtronic's management and Directors are determined to live our Mission Statement with passion and integrity, and we will do our best to deliver results that all stakeholders in this great company can take pride in.